Transcription of the SCL/TAL1 interrupting Locus (Stil) is required for cell proliferation in adult Zebrafish Retinas.

Item request has been placed! ×
Item request cannot be made. ×
loading   Processing Request
  • Additional Information
    • Source:
      Publisher: Elsevier Inc. on behalf of American Society for Biochemistry and Molecular Biology Country of Publication: United States NLM ID: 2985121R Publication Model: Print-Electronic Cited Medium: Internet ISSN: 1083-351X (Electronic) Linking ISSN: 00219258 NLM ISO Abbreviation: J Biol Chem Subsets: MEDLINE
    • Publication Information:
      Publication: 2021- : [New York, NY] : Elsevier Inc. on behalf of American Society for Biochemistry and Molecular Biology
      Original Publication: Baltimore, MD : American Society for Biochemistry and Molecular Biology
    • Subject Terms:
    • Abstract:
      The human oncogene SCL/TAL1 interrupting locus (Stil) is highly conserved in vertebrate species. Previously, we identified a homolog of the Stil gene in zebrafish mutant (night blindness b, nbb), which showed neural defects in the retina (e.g. dopaminergic cell degeneration and/or lack of regeneration). In this research, we examined the roles of Stil in cell proliferation after degeneration in adult zebrafish retinas. We demonstrated that knockdown of Stil gene expression or inhibition of Sonic hedgehog (Shh) signaling transduction decreases the rate of cell proliferation. In contrast, activation of Shh signal transduction promotes cell proliferation. In nbb(+/-) retinas, inhibition of SUFU (a repressor in the Shh pathway) rescues the defects in cell proliferation due to down-regulation of Stil gene expression. The latter data suggest that Stil play a role in cell proliferation through the Shh signal transduction pathway.
    • References:
      Dev Neurobiol. 2008 Feb 15;68(3):392-408. (PMID: 18161852)
      Cancer Cell. 2004 Jun;5(6):587-96. (PMID: 15193261)
      J Neurosci. 2011 Feb 16;31(7):2549-62. (PMID: 21325522)
      J Cell Sci. 2011 Feb 15;124(Pt 4):532-9. (PMID: 21245198)
      J Cell Sci. 2012 Mar 1;125(Pt 5):1353-62. (PMID: 22349705)
      Mol Cell Biol. 2007 Aug;27(16):5887-97. (PMID: 17576815)
      Exp Eye Res. 2008 Nov;87(5):433-44. (PMID: 18718467)
      Cell Mol Life Sci. 2011 Feb;68(4):651-9. (PMID: 20972813)
      BMC Dev Biol. 2006 Jul 26;6:36. (PMID: 16872490)
      Cell Mol Neurobiol. 1991 Dec;11(6):639-59. (PMID: 1685943)
      Proc Natl Acad Sci U S A. 2009 Dec 8;106(49):20812-7. (PMID: 19923430)
      Dev Neurobiol. 2008 Apr;68(5):605-19. (PMID: 18265406)
      J Biol Chem. 2013 Jan 11;288(2):886-93. (PMID: 23166330)
      Dev Biol. 2012 Jan 15;361(2):377-91. (PMID: 22119054)
      Development. 1992 Apr;114(4):913-9. (PMID: 1618153)
      Science. 1990 Dec 7;250(4986):1426-9. (PMID: 2255914)
      Mol Cell Biol. 1991 Nov;11(11):5462-9. (PMID: 1922059)
      Reprod Toxicol. 2012 Apr;33(2):254-63. (PMID: 22265815)
      Nature. 1999 Jun 17;399(6737):691-4. (PMID: 10385121)
      J Cell Sci. 2012 Mar 1;125(Pt 5):1342-52. (PMID: 22349698)
      Invest Ophthalmol Vis Sci. 2007 Jun;48(6):2887-94. (PMID: 17525225)
      Cancer Res. 2008 Oct 1;68(19):7723-9. (PMID: 18829525)
      Proc Natl Acad Sci U S A. 2009 Feb 17;106(7):2236-41. (PMID: 19164594)
      J Neurosci. 2005 May 4;25(18):4565-76. (PMID: 15872104)
      Cell Growth Differ. 1997 Nov;8(11):1171-9. (PMID: 9372240)
      Methods Mol Biol. 2012;884:255-61. (PMID: 22688712)
      Leuk Res. 2003 Jul;27(7):575-82. (PMID: 12681356)
      J Neurosci. 2012 Jan 18;32(3):1096-109. (PMID: 22262907)
      Mol Cell Biol. 2005 Aug;25(15):6660-72. (PMID: 16024801)
      EMBO J. 2011 Oct 21;30(23):4790-804. (PMID: 22020124)
      Dev Biol. 2001 Aug 15;236(2):436-53. (PMID: 11476583)
      Brain Res. 1982 Dec 16;253(1-2):334-6. (PMID: 6295556)
      J Neurosci. 2000 Mar 1;20(5):1893-903. (PMID: 10684890)
      Brain Res. 1985 Jun;352(2):291-5. (PMID: 3928095)
      Nat Genet. 2002 Jun;31(2):135-40. (PMID: 12006978)
      Genomics. 1995 Dec 10;30(3):506-13. (PMID: 8825637)
      Brain Res Dev Brain Res. 1993 Dec 17;76(2):221-32. (PMID: 8149588)
      Breast Cancer Res Treat. 2009 Jun;115(3):505-21. (PMID: 18563554)
      Cancer Res. 2007 May 1;67(9):4022-7. (PMID: 17456584)
      J Neurosci. 2000 Mar 1;20(5):1883-92. (PMID: 10684889)
      Development. 1994 Sep;120(9):2409-19. (PMID: 7956821)
      Genesis. 2001 Oct;31(2):72-7. (PMID: 11668681)
      Vis Neurosci. 1994 Mar-Apr;11(2):209-17. (PMID: 7911678)
      Prog Retin Eye Res. 2011 Nov;30(6):395-404. (PMID: 21742053)
      Brain Res. 1983 Apr 4;264(2):307-10. (PMID: 6405977)
      J Neurobiol. 2000 Sep 5;44(3):289-307. (PMID: 10942883)
      Eur J Neurosci. 2011 Feb;33(4):589-98. (PMID: 21219478)
      Invest Ophthalmol Vis Sci. 2010 Jun;51(6):3244-52. (PMID: 20071673)
    • Grant Information:
      R01 EY013147 United States EY NEI NIH HHS; R01 EY018417 United States EY NEI NIH HHS; R01-EY013147 United States EY NEI NIH HHS; R01-EY018417 United States EY NEI NIH HHS
    • Contributed Indexing:
      Keywords: Cell Proliferation; Neurons; Oncogene; Retina; Zebrafish
    • Accession Number:
      0 (Basic Helix-Loop-Helix Transcription Factors)
      0 (Hedgehog Proteins)
      0 (Proto-Oncogene Proteins)
      0 (Repressor Proteins)
      0 (Shha protein, zebrafish)
      0 (Sufu protein, zebrafish)
      0 (T-Cell Acute Lymphocytic Leukemia Protein 1)
      0 (Zebrafish Proteins)
      0 (tal1 protein, zebrafish)
      8HW4YBZ748 (Oxidopamine)
    • Publication Date:
      Date Created: 20140129 Date Completed: 20140624 Latest Revision: 20211021
    • Publication Date:
      20240829
    • Accession Number:
      PMC3945354
    • Accession Number:
      10.1074/jbc.M113.506295
    • Accession Number:
      24469449